IL10 and myocardial infarction: Although other mediators, including IL-5, IL-10, IL-17, IL-23, and GM-CSF, may also be valuable to target based on experimental findings, to date, there is no available information regarding clinical studies testing the effect of targeting those inflammatory cytokines and growth factors in patients with MI.